Product Information
DALFAMPRIDINE ER 10 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.3992 per EA under NDC 00591253360. Its NADAC has been published 222 times since Jul 6, 2022.
FDA first approved this application on Jan 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591253360
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DALFAMPRIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA206836FDA Approved
1/23/2017
TE Code
AB
On Market Since
5/31/2022
Pharmacological Classes
Price Statistics
The NADAC for DALFAMPRIDINE ER 10 MG TABLET has been published 222 times since Jul 6, 2022, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3992 per EA |
|---|---|
| All-time high | $0.7088 (Nov 13, 2024) |
| All-time low | $0.3640 (May 20, 2026) |
| 52-week high | $0.4824 |
| 52-week low | $0.3640 |
| Median price | $0.4942 |
| Average price | $0.5026 |
| Largest weekly change | +42.4% (Oct 23, 2024) |
| Weeks tracked | 222 |
| Tracking since | Jul 6, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dalfampridine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Potassium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DALFAMPRIDINE ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DALFAMPRIDINE ER 10 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.3992 per EA (NDC 00591253360), effective Sep 30, 2026.
How has the price of DALFAMPRIDINE ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for DALFAMPRIDINE ER 10 MG TABLET has declined 24.8%. It has been tracked across 222 weekly CMS publications since Jul 6, 2022.
What are the highest and lowest recorded NADAC prices for DALFAMPRIDINE ER 10 MG TABLET?
Since Jul 6, 2022, the NADAC for DALFAMPRIDINE ER 10 MG TABLET has ranged from a low of $0.3640 (May 20, 2026) to a high of $0.7088 (Nov 13, 2024), with a median of $0.4942 per EA.
Are there cheaper alternatives to DALFAMPRIDINE ER 10 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DALFAMPRIDINE ER 10 MG TABLET, is $0.3962 per EA — about 1% below DALFAMPRIDINE ER 10 MG TABLET.
Who manufactures DALFAMPRIDINE ER 10 MG TABLET?
DALFAMPRIDINE ER 10 MG TABLET (NDC 00591253360) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.